FDA Cybersecurity Review Timeline: 510(k) & De Novo Guide

Learn the actual timelines for FDA cybersecurity review. Understand 510(k) and De Novo clock stops, RTA hold periods, and how to avoid costly delays.

Keep reading

• FDA

  FDA IDE Cybersecurity Requirements: 2026 Submission Guide

  What the FDA's Feb 2026 guidance recommends for IDE cybersecurity: informed consent, architecture views, SBOM, labeling, and what's not required yet.

• FDA

  MQTT Vulnerabilities in Connected Medical Devices: FDA Risks, Controls, and Deficiency Patterns

  MQTT is one of the most common protocols in IoMT and one of the most commonly misconfigured. The vulnerabilities reviewers cite, the controls that close them, and how to document both for the FDA.

• FDA

  SBOM Diffing and CVE Correlation: The Postmarket Workflow the FDA Expects

  How to operationalize SBOM diffing and CVE correlation across releases so postmarket vulnerability monitoring holds up under FDA Section 524B and the Feb 2026 premarket cybersecurity guidance.

Put this into practice on your device

Every Blue Goat Cyber engagement maps directly to FDA Section 524B and the SPDF - so the evidence you need lands in your submission, not in a separate report.

• Full-Service FDA Premarket Cybersecurity

  End-to-end §524B premarket package: SPDF, threat model, SBOM, pen test, and eSTAR-ready documentation.

Get FDA cleared without the cybersecurity headaches.

30-minute strategy session. No cost, no commitment - just answers from people who've shipped 250+ FDA submissions.